Cargando…
Considering Cell Therapy Product “Good Manufacturing Practice” Status
Autores principales: | Bedford, Patrick, Jy, Juliana, Collins, Lucas, Keizer, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5936751/ https://www.ncbi.nlm.nih.gov/pubmed/29761103 http://dx.doi.org/10.3389/fmed.2018.00118 |
Ejemplares similares
-
Good Manufacturing Practice (GMP) Compliance for Phage Therapy Medicinal Products
por: Bretaudeau, Laurent, et al.
Publicado: (2020) -
Good manufacturing practices for medicinal products for human use
por: Gouveia, Bruno G., et al.
Publicado: (2015) -
Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ Layers
por: Shafa, Mehdi, et al.
Publicado: (2018) -
Exosomes in clinical trial and their production in compliance with good manufacturing practice
por: Chen, Yu-Shuan, et al.
Publicado: (2019) -
Human Platelet Lysate for Good Manufacturing Practice-Compliant Cell Production
por: Oeller, Michaela, et al.
Publicado: (2021)